Blood tests for predicting outcomes in COPD flare-ups
Part of Lungs & breathing clinical trials.
This study looks at how simple blood tests (red blood cells and platelets) can help predict how well people with a sudden worsening of COPD will do. It aims to find better ways to guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have COPD and are currently in the hospital for a sudden worsening of your symptoms within the last 2 weeks.
- Your main reason for being in the hospital is this COPD flare-up, not something else.
- You do not have certain other conditions like lupus, Crohn's disease, or a blood disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a simple blood test to help doctors decide if people having a COPD flare-up need antibiotics or steroids. It may help you get the right treatment faster and avoid unnecessary medications.
This study looks at how common a certain type of white blood cell (eosinophil) is in people with COPD during a flare-up, and whether it affects how they do over time. It may help doctors learn if measuring eosinophils can guide treatment for COPD flare-ups.
This research looks back at hospital records of people with a COPD flare-up who received breathing support. The goal is to find the best ways to use oxygen and breathing machines for future patients.
This study looks at people with COPD who have a sudden worsening of symptoms, called an exacerbation. It tracks what symptoms they have and how they do over time to help doctors understand better how to treat these episodes.
This trial uses two simple blood tests (MxA and CRP) to help doctors decide whether you need antibiotics for a COPD flare-up. It aims to use medicines more wisely and avoid unnecessary side effects.
This study looks at factors that can predict when chronic obstructive pulmonary disease (COPD) will flare up. It may help doctors identify people at higher risk sooner and tailor care to prevent flare-ups.
Hear when a new AECOPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.